Oscar Health, Inc. (OSCR) KPIs and segments
Close on Nov 18, 2026Market cap $8.51BP/E 19.7Yield –
KPI & bộ phận
Chỉ số vận hành và bộ phận làm nên hoạt động của Oscar Health · năm tài chính kết thúc ngày 31 tháng 12
Nhìn nhanh KPI của Oscar Health: 51 chỉ số vận hành, trong đó có Total Effectuated Members (Period-End), Medical Loss Ratio (MLR) và Selling, General, and Administrative Expense Ratio, lấy từ 552 tài liệu nguồn, cùng doanh thu theo bộ phận, sản phẩm và khu vực từ hồ sơ SEC. Mỗi số đều dẫn tới tài liệu gốc. Tất cả chỉ số hiện cả bảng; Cốt lõi chỉ giữ bộ phận và KPI nổi bật. Bảng bộ phận còn có cách xem lũy kế 12 tháng.
Biểu đồ đang trống. Tick vào ô cạnh bất kỳ chỉ số nào ở bảng dưới để vẽ — tick nhiều chỉ số để so sánh trên cùng một biểu đồ.
Bộ phận, KPI nổi bật và mọi chỉ số vận hành từ hồ sơ, thông cáo kết quả và bản trình bày.
| Thêm vào biểu đồ | Chỉ số | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Effectuated Members (Period-End)1 | 2,691,885 | 2,963,002 | 3,174,489 | 2,042,449 | 2,116,904 | 2,027,148 | 2,039,467 | 1,676,970 | 1,654,284 | 1,580,725 | 1,448,408 | 1,036,283 | |
Individual and Small Group Effectuated Members (ACA Marketplace & CHOICE / ICHRA) | 2,691,885 | 2,963,002 | 3,174,489 | 2,042,449 | 2,111,736 | 2,017,058 | 2,021,484 | 1,636,400 | 1,602,993 | 1,522,432 | 1,386,980 | 967,002 | |
Medical Loss Ratio (MLR)(%)2 | 84.0% | 79.2% | 70.5% | 95.4% | 88.5% | 91.1% | 75.4% | 88.1% | 84.6% | 79.0% | 74.2% | 86.4% | |
Net Medical Claims Before Ceded Quota Share Reinsurance (MLR Numerator)($M) | 4,233 | 3,794 | 3,230 | 2,620 | 2,586 | 2,553 | 2,260 | 2,064 | 2,002 | 1,713 | 1,556 | 1,202 | |
Net Earned Premiums Before Ceded Quota Share Reinsurance (MLR Denominator)($M) | 5,042 | 4,789 | 4,581 | 2,747 | 2,924 | 2,803 | 2,996 | 2,344 | 2,365 | 2,167 | 2,096 | 1,391 | |
Selling, General, and Administrative (SG&A) Expense Ratio(%)3 | 14.0% | 14.2% | 15.2% | 18.2% | 17.5% | 18.7% | 15.8% | 19.5% | 19.0% | 19.6% | 18.4% | 25.4% | |
Member Acquisition and Servicing Costs (Broker Commissions, Marketing & Care Guides)($M) | 337 | 326 | 350 | 232 | 247 | 261 | 235 | 196 | 196 | 185 | 171 | ||
Premium Taxes, ACA Exchange User Fees, and Other Regulatory Fees($M) | 202 | 188 | 197 | 117 | 121 | 110 | 97.6 | 116 | 115 | 109 | 92.4 | ||
All Other SG&A Expenses (Corporate, Technology & Administrative Overhead)($M) | 183 | 177 | 160 | 162 | 153 | 163 | 150 | 154 | 150 | 142 | 131 | ||
Adjusted EBITDA (Non-GAAP)($M) | 207 | 415 | 727 | -308 | -102 | -199 | 329 | -113 | -11.6 | 104 | 219 | -112 | |
Direct Policy Premiums Earned (Before ACA Risk Adjustment & Reinsurance)($M)4 | 5,724 | 5,667 | 6,030 | 3,553 | 3,646 | 3,483 | 3,350 | 2,750 | 2,688 | 2,544 | 2,310 | 1,622 | |
ACA Risk Adjustment Transfers Recognized in Premium Revenue($M) | -677 | -872 | -1,443 | -803 | -728 | -692 | -374 | -449 | -375 | -433 | -269 | -286 | |
Reinsurance Premiums Ceded (Quota Share & Excess-of-Loss)($M) | -5.10 | -5 | -5.60 | -2.90 | -3 | -2.70 | -2.50 | -1.90 | 0.10 | -7.60 | -4.60 | -0.80 | |
Assumed Reinsurance Premiums($M) | 0.04 | -0.68 | -0.98 | 0.27 | 8.25 | 15.6 | 22.4 | 46.4 | 55.1 | 60.5 | 57.6 | 54.6 | |
Other Non-Premium Revenues (Marketplace Brokerage & Platform Subsidiaries)($M) | 6.29 | 6.09 | 5.72 | 8.96 | 8.80 | 6.50 | 4.33 | 4.90 | 5.23 | ||||
Direct Medical Claims Incurred (Gross of Reinsurance)($M)2 | 4,308 | 3,873 | 3,294 | 2,661 | 2,627 | 2,562 | 2,268 | 2,088 | 1,986 | 1,680 | 1,524 | 1,158 | |
Ceded Reinsurance Claims Recoveries($M) | -76.1 | -78.4 | -62.7 | -43.2 | -47.8 | -22.2 | -31 | -68.3 | -41.2 | -30 | -19.7 | -10.9 | |
Assumed Reinsurance Claims Incurred($M) | 0.90 | -0.03 | -1.30 | 2.05 | 7.25 | 13.1 | 22.4 | 45.1 | 59.0 | 58.6 | 50.8 | 57.9 | |
Net ACA Risk Adjustment Transfer Payable to CMS (Ending Balance)($M)5 | 2,995 | 4,846 | 3,974 | 2,532 | 1,679 | 2,560 | 1,867 | 1,494 | 1,020 | ||||
Net Risk Adjustment Payable — Current Policy Year($M) | 3,050 | 2,374 | 1,358 | 2,528 | 1,718 | 989 | 281 | 1,493 | 1,025 | ||||
Net Risk Adjustment Payable (Receivable) — Prior Policy Years($M) | -55.7 | 2,473 | 2,616 | 4.20 | -38.8 | 1,571 | 1,586 | 0.90 | -4.60 | ||||
Gross ACA Risk Adjustment Payable to CMS (Ending Balance)($M)2 | 3,125 | 4,942 | 4,052 | 2,588 | 1,771 | 2,647 | 1,955 | 1,558 | 1,084 | 722 | 279 | -766 | |
Gross Risk Adjustment Payable — Current Policy Year($M) | 3,096 | 2,402 | 1,374 | 2,584 | 1,760 | 1,022 | 307 | 1,557 | 1,073 | ||||
Gross Risk Adjustment Payable — Prior Policy Years($M) | 29.7 | 2,540 | 2,677 | 4.20 | 11.8 | 1,625 | 1,648 | 1.10 | 11.1 | ||||
Gross ACA Risk Adjustment Receivable from CMS (Ending Balance)($M)2 | 131 | 95.8 | 77.3 | 56.1 | 92.6 | 87.6 | 87.1 | 64.8 | 63.5 | -20.2 | -10.1 | -4.30 | |
Gross Risk Adjustment Receivable — Current Policy Year($M) | 45.5 | 28 | 16.1 | 56 | 42 | 33.3 | 25.7 | 64.6 | 47.8 | ||||
Gross Risk Adjustment Receivable — Prior Policy Years($M) | 85.3 | 67.8 | 61.2 | 0 | 50.6 | 54.3 | 61.5 | 0.20 | 15.7 | ||||
Net ACA Risk Adjustment Accrual Charge (Rollforward)($M)2 | 677 | 872 | 1,443 | 802 | 728 | 692 | 374 | 439 | |||||
Net Risk Adjustment Accrual — Current Policy Year($M) | 677 | 1,016 | 1,358 | 810 | 729 | 707 | 281 | 468 | |||||
Net Risk Adjustment Accrual — Prior Policy Years Development($M) | 0.80 | -144 | 84.6 | -7.60 | -1.50 | -15 | 92.6 | -29.2 | |||||
Benefits & Unpaid Claims Payable — Gross Liability (Ending Balance)($M)6 | 1,924 | 1,898 | 1,734 | 1,455 | 1,564 | 1,552 | 1,466 | 1,357 | 1,357 | 1,252 | 1,248 | 966 | |
Reinsurance Recoverable Deducted from Benefits Payable($M) | 59.1 | 62.1 | 48.4 | 26.5 | 27.8 | 19.5 | 33.3 | 58.6 | 59.1 | 55 | 59.7 | 57.1 | |
Benefits & Unpaid Claims Payable — Net of Reinsurance (Ending Balance)($M) | 1,890 | 1,861 | 1,708 | 1,448 | 1,557 | 1,553 | 1,452 | 1,316 | 1,316 | 1,214 | 1,206 | 922 | |
Total Reinsurance Recoverable on Paid & Unpaid Claims (Asset)($M) | 271 | 197 | 143 | 99.8 | 159 | 193 | 188 | 292 | 273 | 241 | 243 | 241 | |
Reinsurance Payable (Liability)($M) | 1.70 | 2.60 | 5.10 | 3.60 | 7.30 | 13.4 | 23.6 | 41.3 | 51.1 | 60.1 | 61.9 | 61 | |
Unearned Health Insurance Premiums (Advance Member & CMS Payments)($M) | 160 | 168 | 172 | 166 | 77.1 | 69.5 | 70.9 | 74.4 | 66.1 | 60 | 65.5 | 65.9 | |
Allowance for Credit Losses on Accounts Receivable($M) | 19.1 | 55.3 | 7.17 | 7.23 | 7.28 | 7.35 | 22.7 | 31.3 | 30.1 | 30.4 | 30.6 | 31.6 | |
Net Medical Claims & CAE Incurred (Actuarial Reserve Rollforward)($M)2 | 4,267 | 3,824 | 3,248 | 2,666 | 2,586 | 2,565 | 2,289 | 2,091 | 2,036 | 1,736 | 1,578 | 1,242 | |
Incurred Claims & CAE — Related to Current Policy Year($M) | 4,310 | 3,867 | 3,400 | 2,698 | 2,630 | 2,611 | 2,406 | 2,134 | 2,054 | 1,785 | 1,632 | 1,241 | |
Incurred Claims & CAE — Related to Prior Policy Years (Reserve Development)($M) | -43 | -43 | -151 | -32.2 | -43.8 | -45.7 | -118 | -43.4 | -18.1 | -49.4 | -53.8 | 1.10 | |
Net Medical Claims & CAE Cash Paid (Actuarial Reserve Rollforward)($M)2 | 4,238 | 3,671 | 2,988 | 2,775 | 2,582 | 2,464 | 2,153 | 2,091 | 1,934 | 1,727 | 1,295 | 1,169 | |
Cash Claims & CAE Paid — Current Policy Year($M) | 4,138 | 3,568 | 2,265 | 2,745 | 2,505 | 2,298 | 1,554 | 2,029 | 1,884 | 1,604 | 925 | 1,138 | |
Cash Claims & CAE Paid — Prior Policy Years($M) | 99.9 | 103 | 724 | 30.5 | 76.8 | 166 | 599 | 62 | 49.3 | 123 | 370 | 30.9 | |
Health Insurance Subsidiaries — Total Cash, Cash Equivalents & Investments($M)5 | 8,600 | 9,700 | 7,800 | 5,100 | |||||||||
Health Insurance Subsidiaries — Statutory Deposits with State Regulators($M) | 18.9 | 19.6 | 19.1 | 18.3 | |||||||||
Parent & Non-Insurance Subsidiaries — Total Cash, Cash Equivalents & Investments($M) | 360 | 462 | 279 | 414 | |||||||||
Parent & Non-Insurance Subsidiaries — Restricted Cash & Investments($M) | 8.60 | 9.60 | 9.60 | 14.7 | |||||||||
Consolidated Restricted Cash, Cash Equivalents & Deposits($M) | 22.6 | 24.7 | 24.1 | 30 | 23.9 | 24.4 | 23.8 | 23.9 | 25.8 | 23.1 | 22.3 | 21.7 | |
Noncurrent Restricted Cash & Investments on Deposit($M) | 27.5 | 29.2 | 28.6 | 33 | 27.9 | 31.1 | 31 | 30.9 | 30.1 | 29.9 | 29.8 | 29.9 | |
Gross Investment Income (Before Investment Management Expenses)($M)4 | 91.3 | 83.4 | 61.1 | 49.9 | 52.2 | 54.3 | 46.4 | 42.7 | 50.5 | 50.2 | 43.2 | 35.8 | |
Investment Income — Fixed Maturity Debt Securities($M) | 40.6 | 32.3 | 27.5 | 29.3 | 28.8 | 30.3 | 27.2 | 27.7 | 23 | 17.1 | 14.3 | 13.8 | |
Investment Income — Cash Equivalents & Money Market Funds($M) | 50.7 | 51.0 | 33.6 | 21.7 | 23.1 | 23.7 | 18.6 | 14.0 | 26.0 | 31.4 | 27.3 | 17.3 | |
Investment Management Expenses($M) | 0.46 | 0.34 | 0.52 | 0.33 | 0.14 | 0.31 | 0.30 | 0.25 | 0.21 | 0.17 | 0.17 | 0.21 | |
Accrued Investment Income Receivable (Ending Balance)($M) | 45.3 | 46.6 | 23.1 | 20.2 | 23.4 | 21.8 | 23 | 19.8 | 20.7 | 15.5 | 9 | 6.60 | |
Available-for-Sale (AFS) Fixed Maturity Securities — Due 1 to 5 Years (Fair Value)($M)11 | 1,327 | 1,528 | 1,172 | 1,386 | 1,648 | 1,737 | 1,814 | 1,813 | 1,934 | 1,466 | 737 | 365 | |
AFS Debt Securities — Due Within 1 Year (Fair Value)($M) | 3,022 | 4,480 | 1,995 | 1,217 | 888 | 938 | 752 | 625 | 504 | 364 | 616 | 690 | |
AFS Debt Securities — Due 5 to 10 Years (Fair Value)($M) | 112 | 69.6 | 90.7 | 82.8 | 101 | 107 | 55.9 | 0 | |||||
AFS Debt Securities — Due Within 1 Year (Amortized Cost)($M) | 3,028 | 4,482 | 1,993 | 1,213 | 885 | 936 | 750 | 624 | 503 | 365 | 617 | 691 | |
AFS Debt Securities — Due 1 to 5 Years (Amortized Cost)($M) | 1,359 | 1,535 | 1,168 | 1,372 | 1,635 | 1,725 | 1,806 | 1,816 | 1,909 | 1,468 | 738 | 363 | |
AFS Debt Securities — Due 5 to 10 Years (Amortized Cost)($M) | 116 | 70.1 | 90.8 | 82 | 99 | 106 | 55.5 | 0 | |||||
AFS Securities in Unrealized Loss <12 Months (Fair Value)($M) | 3,765 | 3,318 | 1,041 | 348 | 237 | 760 | 642 | 877 | 554 | 1,261 | 1,036 | 559 | |
AFS Securities in Unrealized Loss <12 Months (Gross Unrealized Loss)($M) | 42.9 | 9.92 | 3.28 | 0.49 | 0.30 | 2.72 | 4.32 | 9.80 | 1.06 | 4.40 | 2.95 | 1.16 | |
AFS Securities in Unrealized Loss <12 Months (Security Lot Count) | 780 | 605 | 270 | 107 | 107 | 243 | 206 | 301 | 165 | 490 | 302 | 133 | |
AFS Securities in Unrealized Loss ≥12 Months (Fair Value)($M) | 0 | 19.8 | 30 | 40.8 | 344 | 0 | 0 | 47.7 | 51 | 81.9 | 16.3 | 30.1 | |
AFS Securities in Unrealized Loss ≥12 Months (Gross Unrealized Loss)($M) | 0 | 0.31 | 0.21 | 0.12 | 1.05 | 0 | 0 | 0.03 | 0.07 | 0.44 | 0.07 | 0.10 | |
AFS Securities in Unrealized Loss ≥12 Months (Security Lot Count) | 0 | 2 | 3 | 5 | 83 | 0 | 0 | 6 | 7 | 16 | 6 | 23 | |
Class A Common Stock Outstanding (1 Vote per Share, Period-End)(M)4 | 275 | 273 | 264 | 262 | 226 | 223 | 218 | 215 | 212 | 206 | 201 | 194 | |
Class B Common Stock Outstanding (20 Votes per Share — Co-Founders / Thrive, Period-End)(M) | 35.2 | 35.2 | 35.6 | 35.8 | 35.7 | 35.5 | 35.5 | 35.5 | 35.5 | 35.5 | 35.5 | 35.5 | |
Incremental Dilutive Shares — Employee Equity Awards (RSUs, PSUs & Options)(M) | 16.4 | 10.5 | 10.8 | 0 | 0 | 0 | 18.0 | -1.58 | 0 | 28.6 | 25.7 | 0 | |
Incremental Dilutive Shares — Convertible Senior Notes (If-Converted Method)(M) | 20.7 | 20.7 | 20.7 | 0 | 0 | 36.7 | -36.7 | 0 | 36.7 | 36.7 | 0 | ||
Anti-Dilutive Securities Excluded from Diluted EPS(M) | 0.19 | 0.65 | 6.63 | -35.4 | 83.0 | 70.2 | 7.95 | 36.6 | 78.8 | 1.55 | 9.06 | -4.17 | |
Centene Corporation (CNC) — Total Consolidated Revenues($M)3 | 50,647 | 53,579 | 49,944 | 49,725 | 49,690 | 48,742 | 46,620 | 40,805 | 42,023 | 39,836 | 40,407 | 39,460 | |
Molina Healthcare, Inc. (MOH) — Total Consolidated Revenues($M)3 | 11,082 | 10,874 | 10,796 | 11,375 | 11,477 | 11,427 | 11,147 | 10,499 | 10,340 | 9,880 | 9,931 | 9,048 | |
Elevance Health, Inc. (ELV) — Total Consolidated Revenues($M)4 | 51,429 | 50,474 | 50,181 | 49,747 | 50,711 | 49,776 | 48,891 | 45,442 | 45,106 | 43,886 | 42,577 | 42,647 | |
The Cigna Group (CI) — Total Consolidated Revenues($M)3 | 73,683 | 71,668 | 68,494 | 72,472 | 69,748 | 67,178 | 65,502 | 65,649 | 63,694 | 60,523 | 57,255 | 51,114 | |
CVS Health Corporation (CVS) — Total Consolidated Revenues($M)4 | 108,399 | 106,096 | 100,426 | 105,693 | 102,871 | 98,915 | 94,588 | 97,710 | 95,428 | 91,234 | 88,437 | 93,813 | |
UnitedHealth Group Incorporated (UNH) — Total Consolidated Revenues($M)4 | 112,694 | 112,032 | 111,721 | 113,215 | 113,161 | 111,616 | 109,575 | 100,807 | 100,820 | 98,855 | 99,796 | 94,427 | |
Humana Inc. (HUM) — Total Consolidated Revenues($M)4 | 41,155 | 40,867 | 39,648 | 32,515 | 32,649 | 32,388 | 32,112 | 29,213 | 29,397 | 29,540 | 29,611 | 26,462 | |
BEA Personal Consumption Expenditures — Health Care Services (DHLCRC1Q027SBEA, SAAR)($M) | 3,858,700 | 3,790,300 | 3,699,900 | 3,667,000 | 3,614,900 | 3,529,800 | 3,464,700 | 3,417,800 | 3,358,200 | 3,288,200 | 3,244,400 | 3,159,400 | |
Total Consolidated Revenue($M)6 | 5,139 | 4,880 | 4,647 | 2,805 | 2,986 | 2,864 | 3,046 | 2,392 | 2,424 | 2,219 | 2,142 | 1,432 | |
Premiums Earned (Net of Risk Adjustment & Ceded Reinsurance)($M) | 5,042 | 4,789 | 4,581 | 2,747 | 2,924 | 2,803 | 2,996 | 2,345 | 2,368 | 2,164 | 2,094 | 1,390 | |
Net Investment Income($M) | 90.8 | 83.1 | 60.6 | 50.9 | 52 | 54 | 46.1 | 42.4 | 50.3 | 50 | 43 | 35.5 | |
Medical / Policyholder Benefits Expense($M) | 4,233 | 3,794 | 3,230 | 2,620 | 2,586 | 2,553 | 2,260 | 2,065 | 2,004 | 1,709 | 1,555 | 1,205 | |
Selling, General, and Administrative Expenses($M) | 722 | 691 | 706 | 511 | 522 | 535 | 483 | 466 | 460 | 435 | 394 | 364 | |
Depreciation and Amortization($M) | 6.50 | 6 | 7 | 7.90 | 7.30 | 7 | 6.70 | 9.20 | 7.50 | 7.60 | 7.80 | 7.70 | |
Total Operating Expenses($M) | 4,961 | 4,492 | 3,943 | 3,139 | 3,115 | 3,094 | 2,749 | 2,540 | 2,472 | 2,152 | 1,957 | 1,577 | |
Earnings (Loss) from Operations($M)3 | 178 | 389 | 704 | -334 | -129 | -231 | 297 | -148 | -48.4 | 67.8 | 186 | -146 | |
Interest Expense($M) | 4.70 | 4.70 | 5.40 | -1.10 | 6.90 | 5.80 | 6 | 6 | 5.80 | 6 | 5.90 | 6.20 | |
Earnings (Loss) Before Income Taxes($M) | 175 | 383 | 699 | -353 | -139 | -234 | 288 | -154 | -52.3 | 60.9 | 179 | -151 | |
Income Tax Expense (Benefit)($M) | 8.10 | 21.2 | 19.8 | -0.20 | -1.80 | -5 | 12.7 | -0.40 | 2.10 | 4.60 | 1 | -0.80 | |
Net Income (Loss) Attributable to Oscar Health, Inc.($M)5 | 167 | 362 | 679 | -353 | -137 | -228 | 275 | -154 | -54.6 | 56.2 | 177 | -150 | |
Consolidated Net Income (Loss) Including Noncontrolling Interests($M) | 167 | 362 | 679 | -352 | -138 | -229 | 276 | -153 | -54.4 | 56.3 | 178 | -150 | |
Earnings (Loss) per Share — Basic($) | 0.54 | 1.20 | 2.28 | -0.53 | -0.89 | 1.10 | -0.22 | 0.24 | 0.77 | ||||
Earnings (Loss) per Share — Diluted($) | 0.49 | 1.10 | 2.07 | -0.53 | -0.89 | 0.92 | -0.22 | 0.20 | 0.62 | ||||
Weighted-Average Common Shares — Basic(M) | 309 | 302 | 298 | 259 | 256 | 251 | 243 | 239 | 231 | ||||
Weighted-Average Common Shares — Diluted(M) | 346 | 333 | 330 | 259 | 256 | 306 | 243 | 304 | 294 | ||||
Total Consolidated Assets($M)6 | 10,009 | 11,227 | 9,290 | 6,325 | 5,746 | 6,384 | 5,844 | 4,841 | 4,483 | 5,006 | 4,419 | 3,602 | |
Cash and Cash Equivalents($M) | 4,467 | 4,076 | 4,805 | 2,774 | 2,149 | 2,599 | 2,237 | 1,551 | 1,206 | 2,268 | 2,231 | 1,870 | |
Short-Term Investments($M) | 3,022 | 4,480 | 1,995 | 1,217 | 888 | 938 | 752 | 625 | 504 | 364 | 616 | 690 | |
Long-Term Investments($M) | 1,442 | 1,601 | 1,267 | 1,471 | 1,751 | 1,846 | 1,873 | 1,815 | 1,934 | 1,466 | 737 | 365 | |
Accounts Receivable, Net($M) | 303 | 380 | 587 | 363 | |||||||||
Total Current Assets($M) | 8,316 | 9,373 | 7,777 | 4,613 | 3,763 | 4,313 | 3,775 | 2,845 | 2,368 | 3,359 | 3,504 | 3,061 | |
Property, Equipment, and Capitalized Software, Net($M) | 109 | 102 | 94.2 | 88.3 | 83.4 | 77.7 | 72 | 66.8 | 66.6 | 64 | 61.4 | 61.9 | |
Total Consolidated Liabilities($M)5 | 7,783 | 9,172 | 7,623 | 5,345 | 4,719 | 5,223 | 4,508 | 3,824 | 3,318 | 3,866 | 3,385 | 2,795 | |
Accounts Payable and Accrued Liabilities($M) | 589 | 526 | 506 | 507 | 557 | 584 | 634 | 432 | 396 | 348 | 303 | 273 | |
Total Current Liabilities($M) | 7,302 | 8,690 | 7,140 | 4,863 | 3,977 | 4,866 | 4,149 | 3,463 | 2,955 | 3,502 | 3,019 | 2,429 | |
Long-Term Debt($M) | 432 | 432 | 431 | 430 | 686 | 300 | 300 | 300 | 299 | 299 | 299 | 299 | |
Total Oscar Health, Inc. Stockholders' Equity($M) | 2,223 | 2,052 | 1,664 | 978 | 1,024 | 1,158 | 1,333 | 1,014 | 1,163 | 1,138 | 1,032 | 804 | |
Total Stockholders' Equity (Including Noncontrolling Interests)($M) | 2,226 | 2,055 | 1,667 | 981 | 1,027 | 1,161 | 1,336 | 1,016 | 1,165 | 1,141 | 1,034 | 806 | |
Net Cash Provided by (Used in) Operating Activities($M)4 | -1,201 | 2,092 | 2,619 | 672 | -965 | 509 | 879 | 347 | -500 | 497 | 634 | 297 | |
Capital Expenditures (Property, Equipment & Capitalized Software)($M) | 11.3 | 11.8 | 8.80 | 9.10 | 9 | 9.30 | 9 | 6.80 | 7.60 | 7.60 | 5.90 | 6.10 | |
Stock-Based Compensation Expense($M) | 22.3 | 20.7 | 16 | 18.1 | 20.5 | 24.1 | 25 | 25.9 | 29.3 | 28.7 | 25.9 | 26.1 | |
Net Cash Provided by (Used in) Investing Activities($M) | 1,579 | -2,835 | -590 | -48.7 | 150 | -168 | -174 | -31.4 | -578 | -478 | -301 | 173 | |
Net Cash Provided by (Used in) Financing Activities($M) | 10.9 | 13.3 | -3.60 | 8.20 | 364 | 22.1 | 4.90 | 3.80 | 18.6 | 18.7 | 27.3 | 1.10 | |
In nghiêng là số StockData tự tính từ số đã báo cáo (rê chuột để xem công thức). Số có gạch chân chấm là số đọc từ câu chữ trong thông cáo kết quả và bản trình bày; rê chuột để xem đúng câu đó. Tick vào một dòng để thêm vào biểu đồ phía trên (tối đa 8 đường).
Phương pháp và các chỉ số bị loại
- Fiscal Calendar & Filing Scope: Oscar Health, Inc. operates on a calendar fiscal year ending December 31 (Q1 ends March 31, Q2 ends June 30, Q3 ends September 30, Q4 ends December 31). Latest company filings reflected: Q3 2026 Form 10-Q and Form 8-K Item 2.02 (period ended September 30, 2026, filed November 5, 2026), June 2026 Investor Day Presentation & Fact Sheet, 2026 Definitive Proxy Statement (DEF 14A, filed April 22, 2026), FY2025 Form 10-K (filed February 13, 2026), and IPO Prospectus Form 424B4 (filed March 4, 2021). External CMS ACA Marketplace Open Enrollment Public Use Files extend through Plan Year 2026 (FY2026), and CMS Monthly Medicare Advantage / Part D enrollment extends through November 2026 (2026-11).
- Underwriting Mechanics, ACA Risk Adjustment & Reinsurance: Oscar operates primarily in the Affordable Care Act (ACA) Individual and Small Group (including CHOICE / ICHRA) health insurance market across 18 states at year-end 2025 (expanded to 20 states in Plan Year 2026 and 21 states / 713 counties entering 2027 Open Enrollment). Direct policy premiums (91% earned via federal CMS Advanced Premium Tax Credit subsidies in Q3 2026 vs. 93% in Q3 2025) are adjusted each quarter for estimated ACA risk adjustment transfers payable to CMS ($2,994.6 million net payable as of September 30, 2026) and quota share / excess-of-loss reinsurance.
- Single Reportable Segment & SG&A Expense Disaggregation (ASU 2023-07): Oscar manages a single reportable insurance and healthcare technology segment alongside three wholly owned individual-market brokerage and enrollment platforms acquired in 2025 (Lucie, Inc., Trove Group, Inc., and HealthInsurance.org, LLC — the 'Marketplace Subsidiaries'). Under ASU 2023-07, Oscar disaggregates consolidated SG&A into three operational buckets: Member acquisition and servicing costs, Premium taxes / exchange fees / regulatory fees, and All other corporate & technology SG&A.
- Parent-Company Schedule I Evaluation: Oscar Health, Inc. (the parent registrant) is a holding company with $0 direct insurance underwriting premium revenue; all regulated health plans are operated by state-licensed insurance and HMO subsidiaries subject to NAIC statutory risk-based capital requirements ($1,037.8 million combined statutory capital and surplus at December 31, 2025). Accordingly, Consolidated minus Parent-Only subtraction does not apply; Group 5 reports Parent-Only Schedule I assets, cash, convertible senior notes, and capital contributions directly.
- Data Integrity & Permitted Period Splits: Every cell displays an exact published figure from Oscar Health SEC filings or official external regulatory/statistical agencies (CMS, BLS, BEA, U.S. Census Bureau, and peer SEC XBRL filings), plus permitted standalone-quarter subtractions from cumulative year-to-date cash flow and footnote rollforward disclosures (Q2 = 6M − Q1, Q3 = 9M − 6M, and Q4 = FY − 9M, explicitly annotated on each derived cell). Approximate figures qualified by directional or rounding modifiers (such as 'approximately 2,305 employees' or 'approximately $2.3 billion' interim statutory surplus) are excluded from numeric cells.
Không hiện vì thiếu các kỳ gần đây (11)
- Cigna+Oscar Small Group Co-Branded Membership (non-renewed after December 31, 2024; declined to 5,168 run-off members at Q3 2025 and reported as '—' / zero active plans across Q1–Q3 2026)
- Oscar Medicare Advantage Membership (exited commercial Medicare Advantage offerings after Plan Year 2023; 1,781 members at year-end 2023 and '—' from FY2024 onward)
- Exited State ACA Markets — California, Connecticut, Colorado, and Arkansas Year-End Membership (Oscar exited Colorado and Arkansas after 2022 and California and Connecticut after 2024, reported as '—' in FY2025 Form 10-K Item 1)
- Legacy Pre-2024 InsuranceCo Administrative Expense Ratio, InsuranceCo Combined Ratio, Adjusted Administrative Expense Ratio, and InsuranceCo Adjusted EBITDA (retired by management beginning in FY2024 earnings releases and replaced by the consolidated SG&A Expense Ratio in Group 2)
- Legacy +Oscar External Client Platform Membership (discontinued as a standalone KPI after realignment of external HealthOSP client contracts into single-segment operations)
- Total Employees Headcount (disclosed only with approximate modifiers — 'approximately 2,305 employees' in FY2025 Form 10-K Item 1 and '~2,300 full-time employees' in the 2025 Impact Report)
- Interim Quarterly Statutory Capital & Surplus Estimates (disclosed in Form 10-Q MD&A with approximate bounds such as 'estimated to be approximately $2.3 billion' at Q3 2026; exact audited year-end NAIC statutory capital and surplus is reported in Group 4)
- CMS Federal Premium Subsidy Percentage of Direct Policy Premiums — 91% in Q3 2026 vs. 93% in Q3 2025 (newly added in Q2–Q3 2026 Form 10-Q filings without a Q1 2026 comparative percentage; documented in sheet notes)
- Single-Period 2025 Impact Report & EEO-1 Workforce Metrics — 70% paperless billing opt-in, 85% Oswell AI question completion rate, 67% Care Guide response time reduction, and October 2024 EEO-1 headcount of 2,038 (published for a single reporting period only, lacking two consecutive annual periods)
- CMS Medical Loss Ratio (MLR) Issuer-Level Public Use Files (latest federal CMS MLR PUF release covers Plan Year 2024, lagging FY2025; current state-level CMS Open Enrollment PUFs through Plan Year 2026 are included in Group 6)
- Full-Year 2026 Financial Guidance & 2029 Investor Day Target Ranges — FY2026 Revenue ($19.0B–$19.3B), MLR (80.5%–81.5%), SG&A Expense Ratio (15.1%–15.6%), and Earnings from Operations ($850M–$950M) ranges, plus 2027 Open Enrollment footprint targets (forward-looking ranges rather than historical single-point actuals)
Dữ liệu cập nhật 2026-11-14.
Mỗi KPI một trang riêng
Đầy đủ lịch sử, biểu đồ, nguồn và cách trích dẫn cho từng chỉ số
Effectuated Membership & State Geographic Footprint (Key #1)
Underwriting Ratios, Premium/Claims Waterfall & Non-GAAP Profitability (Key #2)
ACA Risk Adjustment Balances & Unpaid Claims Reserve Rollforward (Key #3)
- Net ACA Risk Adjustment Transfer Payable to CMS (Ending Balance) ($M)9 kỳ
- Benefits & Unpaid Claims Payable — Gross Liability (Ending Balance) ($M)28 kỳ
- Net Medical Claims & CAE Incurred (Actuarial Reserve Rollforward) ($M)27 kỳ
- Net Medical Claims & CAE Cash Paid (Actuarial Reserve Rollforward) ($M)27 kỳ
Regulated Subsidiary Liquidity, Statutory Capital & Investment Portfolio
- Health Insurance Subsidiaries — Total Cash, Cash Equivalents & Investments ($M)4 kỳ
- Combined Statutory Capital and Surplus of Health Insurance Subsidiaries (NAIC SAP) ($M)6 kỳ
- Gross Investment Income (Before Investment Management Expenses) ($M)15 kỳ
- Available-for-Sale (AFS) Fixed Maturity Securities — Due 1 to 5 Years (Fair Value) ($M)19 kỳ
Parent Company (Schedule I), Dual-Class Share Structure, Tax Carryforwards, Leases & Governance
- Parent Registrant (Schedule I) — Total Standalone Assets ($M)6 kỳ
- Class A Common Stock Outstanding (1 Vote per Share, Period-End) (M)13 kỳ
- Gross Deferred Tax Assets (Before Valuation Allowance) ($M)6 kỳ
- Operating Lease Undiscounted Future Cash Commitments — Total ($M)5 kỳ
- Median Employee Annual Total Compensation (Item 402(u) Pay Ratio) ($)4 kỳ
External Regulatory Enrollment & Pricing — CMS ACA Marketplace (Through 2026) & CMS Monthly MA/PDP (Through Nov 2026)
- U.S. ACA Marketplace Total Plan Selections (Open Enrollment — Through Plan Year 2026) (M)7 kỳ
- Florida — Total CMS ACA Marketplace Plan Selections (Largest ACA State & #1 Oscar Market) (M)7 kỳ
- U.S. ACA Marketplace Average Gross Monthly Premium Before APTC (HealthCare.gov) ($)4 kỳ
- U.S. Medicare Advantage & Part D Combined Enrollment (CMS Monthly Summary) (M)39 kỳ
External Industry Peer Benchmarks (Managed Care Filings) & U.S. Healthcare Macro Indicators (FRED)
- Centene Corporation (CNC) — Total Consolidated Revenues ($M)31 kỳ
- Molina Healthcare, Inc. (MOH) — Total Consolidated Revenues ($M)31 kỳ
- Elevance Health, Inc. (ELV) — Total Consolidated Revenues ($M)31 kỳ
- The Cigna Group (CI) — Total Consolidated Revenues ($M)31 kỳ
- CVS Health Corporation (CVS) — Total Consolidated Revenues ($M)31 kỳ
- UnitedHealth Group Incorporated (UNH) — Total Consolidated Revenues ($M)31 kỳ
- Humana Inc. (HUM) — Total Consolidated Revenues ($M)31 kỳ
- BLS PPI — Direct Health and Medical Insurance Carriers (PCU524114524114, Index) (×)94 kỳ
- BLS PPI — General Medical and Surgical Hospitals (PCU622110622110, Index) (×)94 kỳ
- BLS PPI — Offices of Physicians (PCU621111621111, Index) (×)94 kỳ
- BLS CPI-U — Medical Care (CPIMEDSL, Index) (×)93 kỳ
- BLS CPI-U — Medical Care Services (CUSR0000SAM2, Index) (×)93 kỳ
- BLS CPI-U — Hospital and Related Services (CUSR0000SEMD, Index) (×)93 kỳ
- BLS CPI-U — Physicians' Services (CUSR0000SEMC, Index) (×)93 kỳ
- BLS CPI-U — Medical Care Commodities & Prescription Drugs (CUSR0000SAM1, Index) (×)93 kỳ
- BLS Employment — Total Health Care Sector (CES6562000101) (M)94 kỳ
- BLS Employment — Ambulatory Health Care Services (CES6562100001) (M)94 kỳ
- BLS Employment — Hospitals (CES6562200001) (M)94 kỳ
- BLS Employment — Nursing and Residential Care Facilities (CES6562300001) (M)94 kỳ
- BEA Personal Consumption Expenditures — Health Care Services (DHLCRC1Q027SBEA, SAAR) ($M)31 kỳ
- U.S. Census Retail Sales — Pharmacies and Drug Stores (MRTSSM44611USS) ($M)92 kỳ
- U.S. Census Retail Sales — Health and Personal Care Stores (RSCCAS) ($M)93 kỳ
Consolidated Financial Statements Context (Income Statement, Balance Sheet & Cash Flows)
Tài liệu nguồn mới nhất
Các tài liệu được trích nhiều nhất cho số liệu mới nhất của Oscar Health
- Oscar Health Q3 2026 10-Q (filed 2026-11-05) ↗
- Oscar Health FY2025 10-K (filed 2026-02-13) ↗
- Oscar Health 10-Q (2026-11-05) ↗
- Oscar Health 10-K (2026-02-13) ↗
- CMS Health Insurance Exchanges Open Enrollment Public Use File (2026) ↗
- Oscar Health FY2026Q3 Form 8-K Earnings Release (filed 2026-11-05) ↗
- Oscar Health FY2025Q4 Form 8-K Earnings Release (filed 2026-02-10) ↗
- OSCR 10-Q (2026-11-05, XBRL us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense) ↗
- OSCR 10-Q (2026-11-05, XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
- OSCR 10-Q (2026-11-05, XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet) ↗
- OSCR 10-K (2026-02-13, XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet) ↗
- OSCR 10-Q (2026-11-05, XBRL us-gaap:PaymentsForLossesAndLossAdjustmentExpense) ↗
See a number that looks wrong?